BRPI1007725A2 - composição de revestimento de liberação imediata com propriedades melhoradas de barreira à umidade, suspensão aquosa, substrato oral revestido, forma de dosagem oral e método para preparação da mesma - Google Patents

composição de revestimento de liberação imediata com propriedades melhoradas de barreira à umidade, suspensão aquosa, substrato oral revestido, forma de dosagem oral e método para preparação da mesma

Info

Publication number
BRPI1007725A2
BRPI1007725A2 BRPI1007725A BRPI1007725A BRPI1007725A2 BR PI1007725 A2 BRPI1007725 A2 BR PI1007725A2 BR PI1007725 A BRPI1007725 A BR PI1007725A BR PI1007725 A BRPI1007725 A BR PI1007725A BR PI1007725 A2 BRPI1007725 A2 BR PI1007725A2
Authority
BR
Brazil
Prior art keywords
preparation
dosage form
coating composition
aqueous suspension
barrier properties
Prior art date
Application number
BRPI1007725A
Other languages
English (en)
Inventor
Jason Teckoe
Thomas P Farrel
Original Assignee
Bpsi Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43068684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1007725(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bpsi Holdings Llc filed Critical Bpsi Holdings Llc
Publication of BRPI1007725A2 publication Critical patent/BRPI1007725A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D129/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal, or ketal radical; Coating compositions based on hydrolysed polymers of esters of unsaturated alcohols with saturated carboxylic acids; Coating compositions based on derivatives of such polymers
    • C09D129/02—Homopolymers or copolymers of unsaturated alcohols
    • C09D129/04—Polyvinyl alcohol; Partially hydrolysed homopolymers or copolymers of esters of unsaturated alcohols with saturated carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
    • C08K3/24—Acids; Salts thereof
    • C08K3/26—Carbonates; Bicarbonates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/34—Silicon-containing compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00—Compositions of unspecified macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/02—Homopolymers or copolymers of acids; Metal or ammonium salts thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/04—Homopolymers or copolymers of esters
    • C08L33/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical
    • C08L33/08—Homopolymers or copolymers of acrylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D7/00—Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
    • C09D7/40—Additives
    • C09D7/60—Additives non-macromolecular
    • C09D7/61—Additives non-macromolecular inorganic
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D7/00—Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
    • C09D7/40—Additives
    • C09D7/65—Additives macromolecular
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
    • C08K3/24—Acids; Salts thereof
    • C08K3/26—Carbonates; Bicarbonates
    • C08K2003/262—Alkali metal carbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
BRPI1007725A 2009-05-12 2010-04-28 composição de revestimento de liberação imediata com propriedades melhoradas de barreira à umidade, suspensão aquosa, substrato oral revestido, forma de dosagem oral e método para preparação da mesma BRPI1007725A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17738009P 2009-05-12 2009-05-12
PCT/US2010/032748 WO2010132204A1 (en) 2009-05-12 2010-04-28 Enhanced moisture barrier immediate release film coating systems and substrates coated therewith

Publications (1)

Publication Number Publication Date
BRPI1007725A2 true BRPI1007725A2 (pt) 2016-02-16

Family

ID=43068684

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1007725A BRPI1007725A2 (pt) 2009-05-12 2010-04-28 composição de revestimento de liberação imediata com propriedades melhoradas de barreira à umidade, suspensão aquosa, substrato oral revestido, forma de dosagem oral e método para preparação da mesma

Country Status (13)

Country Link
US (2) US8647645B2 (pt)
EP (1) EP2429505B1 (pt)
JP (1) JP2012526815A (pt)
KR (1) KR101783945B1 (pt)
CN (1) CN102421423B (pt)
AU (1) AU2010248060A1 (pt)
BR (1) BRPI1007725A2 (pt)
CA (1) CA2759985A1 (pt)
IL (1) IL216241A0 (pt)
MX (1) MX2011011919A (pt)
RU (1) RU2528095C2 (pt)
WO (1) WO2010132204A1 (pt)
ZA (1) ZA201107632B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012120366A1 (en) * 2011-03-09 2012-09-13 Ideal Cures Pvt. Ltd. Novel moisture barrier immediate release film coating composition
EP2705088A1 (en) * 2011-05-04 2014-03-12 Dow Global Technologies LLC Talc-free polyvinyl alcohol composition
WO2013045352A1 (de) 2011-09-30 2013-04-04 Basf Se Verfahren zur herstellung von festen pigmenthaltigen filmüberzugsmitteln in form von granulaten auf basis von magensaftresistenten filmbildnern für pharmazeutische dosierungsformen
AT513519B1 (de) * 2012-10-23 2014-07-15 Gebro Holding Gmbh Filmbeschichtungszusammensetzung
JP6067342B2 (ja) * 2012-11-16 2017-01-25 花王株式会社 シート状化粧料
MX357575B (es) * 2013-03-01 2018-07-16 Bpsi Holdings Llc Recubrimientos de pelicula de liberacion retardada que contienen silicato de calcio y sustratos recubiertos con los mismos.
MX378845B (es) * 2014-01-21 2025-03-10 Bpsi Holdings Llc Revestimientos de pelicula de liberacion inmediata que contienen gliceridos de cadena media y sustratos revestidos con los mismos.
WO2015120201A1 (en) 2014-02-05 2015-08-13 Kashiv Pharma, Llc Abuse-resistant drug formulations with built-in overdose protection
WO2015145461A1 (en) * 2014-03-26 2015-10-01 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
US9777129B2 (en) 2014-04-11 2017-10-03 Georgia-Pacific Consumer Products Lp Fibers with filler
US9777143B2 (en) * 2014-04-11 2017-10-03 Georgia-Pacific Consumer Products Lp Polyvinyl alcohol fibers and films with mineral fillers and small cellulose particles
CN105521493A (zh) * 2014-09-28 2016-04-27 天津尖峰弗兰德医药科技发展有限公司 一种薄膜包衣预混辅料
EP3240842B1 (en) 2015-01-01 2023-05-03 Ideal Cures Pvt. Ltd. Novel film coating composition
HK1247105A1 (zh) 2015-04-02 2018-09-21 Theravance Biopharma R&D Ip, Llc Mu类鸦片受体拮抗剂与类鸦片药剂的组合剂型
JP6396251B2 (ja) * 2015-04-06 2018-09-26 日本酢ビ・ポバール株式会社 フィルムコーティング組成物並びに経口固形製剤及びその製造方法
KR102158339B1 (ko) * 2016-02-05 2020-09-21 삼진제약주식회사 인습성이 개선된 카르베딜롤 속방성 제제
CN105997918A (zh) * 2016-06-03 2016-10-12 天津博科林药品包装技术有限公司 一种掩盖特殊气味的薄膜包衣剂
JP7072373B2 (ja) * 2016-11-29 2022-05-20 三生医薬株式会社 フィルムコーティング用組成物および固形製剤
CN109527963B (zh) * 2018-11-19 2020-05-05 珠海格力电器股份有限公司 一种根据颜色变化喷洒水雾的烹饪器具、方法及控制方法
CN117440800A (zh) * 2021-06-07 2024-01-23 R·P·舍勒科技有限责任公司 用于对水分敏感的药物组合物的保护性包衣
CN115785596B (zh) * 2022-12-08 2024-05-31 华南理工大学 一种含有疏水涂层且负载纳米阻气材料的改性pva薄膜及其制备方法与应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4828841A (en) 1984-07-24 1989-05-09 Colorcon, Inc. Maltodextrin coating
US4643894A (en) 1984-07-24 1987-02-17 Colorcon, Inc. Maltodextrin coating
JPS61100519A (ja) 1984-10-23 1986-05-19 Shin Etsu Chem Co Ltd 医薬用硬質カプセル
US6468561B1 (en) 1986-06-19 2002-10-22 Bpsi Holdings, Inc. Aqueous film coating with improved properties
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
US5378759A (en) 1992-04-23 1995-01-03 Rohm And Haas Company Polymer blends
US5330759A (en) * 1992-08-26 1994-07-19 Sterling Winthrop Inc. Enteric coated soft capsules and method of preparation thereof
US6207199B1 (en) * 1994-01-27 2001-03-27 The Board Of Regents Of The University Of Oklahoma Process for making a particulate support matrix for making a rapidly dissolving dosage form
GB9414045D0 (en) 1994-07-12 1994-08-31 Berwind Pharma Service Moisture barrier film coating composition, method, and coated form
US5733575A (en) 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
CN1165296C (zh) 1998-09-30 2004-09-08 Basf公司 水溶性或水可分散性含聚醚聚合物作为在药物给药形式中的包衣剂、粘合剂和/或成膜赋形剂的应用
US6448323B1 (en) 1999-07-09 2002-09-10 Bpsi Holdings, Inc. Film coatings and film coating compositions based on polyvinyl alcohol
US6420473B1 (en) 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
JP2002003366A (ja) * 2000-06-23 2002-01-09 Freunt Ind Co Ltd 固形薬剤用水系コーティング剤組成物
IT1319210B1 (it) * 2000-10-13 2003-09-26 Italiano Biochimico Lisapharma Pellicola per la somministrazione dermica e transdermica di principiattivi.
CN1829499A (zh) * 2003-05-29 2006-09-06 格利康科技集团有限责任公司 稳定并控制传递(－)－羟基柠檬酸的方法和组合物
BRPI0412752B8 (pt) * 2003-07-24 2021-05-25 Glaxosmithkline Llc composição de filme de dissolução oral
US8277844B2 (en) 2003-08-20 2012-10-02 Shionogi & Co., Ltd. Coating composition
ATE549015T1 (de) 2003-10-31 2012-03-15 Hexal Ag Pharmazeutische wirkstoffhaltige formulierung mit überzug
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
BE1016128A6 (fr) * 2004-07-22 2006-03-07 Messadek Jallal Combinaisons therapeutiques
TW200626185A (en) 2004-12-17 2006-08-01 Bpsi Holdings Inc Enteric film coating composition containing entericpolymer micronized with detackifier
WO2006111980A2 (en) 2005-04-20 2006-10-26 Ideal Cures Pvt. Ltd. Pva based film coating and film coating compositions
KR100758592B1 (ko) * 2006-08-29 2007-09-13 주식회사유한양행 필름코팅용 조성물
JP5784878B2 (ja) 2007-03-07 2015-09-24 ノバルティス アーゲー 経口投与可能なフィルム

Also Published As

Publication number Publication date
US9028862B2 (en) 2015-05-12
US8647645B2 (en) 2014-02-11
AU2010248060A1 (en) 2011-10-27
EP2429505A4 (en) 2013-04-24
CA2759985A1 (en) 2010-11-18
US20100291183A1 (en) 2010-11-18
MX2011011919A (es) 2012-01-27
KR20120044291A (ko) 2012-05-07
ZA201107632B (en) 2012-06-27
JP2012526815A (ja) 2012-11-01
RU2011150228A (ru) 2013-06-20
KR101783945B1 (ko) 2017-10-10
RU2528095C2 (ru) 2014-09-10
CN102421423A (zh) 2012-04-18
EP2429505A1 (en) 2012-03-21
US20140128477A1 (en) 2014-05-08
WO2010132204A1 (en) 2010-11-18
IL216241A0 (en) 2012-01-31
EP2429505B1 (en) 2015-11-04
CN102421423B (zh) 2014-11-05

Similar Documents

Publication Publication Date Title
BRPI1007725A2 (pt) composição de revestimento de liberação imediata com propriedades melhoradas de barreira à umidade, suspensão aquosa, substrato oral revestido, forma de dosagem oral e método para preparação da mesma
BRPI0916922A2 (pt) composição farmacêutica de liberação prolongada de entacapona ou sais da mesma
GB0813548D0 (en) Aqueous coating composition and preparation thereof
BRPI0915451A2 (pt) sistema de revestimento, peça revestida e método para fabricação da mesma
BRPI0818680A2 (pt) composição farmacêutica, preparação farmacêutica, e método para preparar um forma de dosagem oral farmacêutica
BRPI0921629A2 (pt) composição de revestimento anti-incrustação compreendendo nanopartículas
DE602008000685D1 (de) Wässrige Copolymerlösung und Beschichtungszusammensetzung
BRPI0916877A2 (pt) composição farmacêutica e administração da mesma
BRPI1009580A2 (pt) composicao de revestimento de semente, método para preparar uma semente revestida, semente revestida, e, uso de partículas inorgânicas
BR112012009712A2 (pt) metodo para a preparação de uma composição antimicrobiana composição antimicrobiana e filamento de escova
EP2256142A4 (en) CARBODIIMIDE COMPOUND, CARBODIIMIDE COMPOSITION, AND WATERPROOF COATING COMPOSITION
BRPI0817407A2 (pt) Composição de revestimento, produto revestido e método para formar um produto revestido
BRPI0913441A2 (pt) Composição prebiótica e métodos de produção e uso da mesma
BRPI0914599A2 (pt) métodos para tratar ou prevenir câncer, para inibir uma pim quinase, e para fabricar um composto, composto, composição farmacêutico, e, uso de um composto
BRPI0908021A2 (pt) Composto, composição farmacêutica, e, usos do composto ou da composição farmacêutica
BRPI1008869A2 (pt) nanopartícula, composto, composição farmacêutica, método para tratar câncer ou metástase, e, método de liberação prolongada de um composto de platina
BRPI1014865A2 (pt) "composição e formulação farmacêutica comreendendo derivados de nitrocatecol, e, método para fabricar uma composição ou formulação farmacêutica"
EP2513225A4 (en) LOCAL ACTIVE INGREDIENT RELIEF FROM SELF-ORDINATED COATINGS
BR112012003842A2 (pt) composição farmacêutica, método de formulação e uso da mesma
PL2230932T3 (pl) Powlekany preparat farmaceutyczny lub nutraceutyczny o zwiększonym uwalnianiu substancji aktywnej w jelicie grubym
BR112012003075A2 (pt) composição retardante de chamas livre de halogênio, fio revestido e método para fazer um fio revestido
EP2298282A4 (en) COMBINING MEDICAMENTS HAVING DIFFERENT PHYSICAL PROPERTIES IN A SINGLE PHARMACEUTICAL FORM
BRPI0913221A2 (pt) camada de revestimento rígido e método para formação da mesma
BRPI0920862A2 (pt) composição, método para fabricação da mesma, e uso da mesma
BRPI0809601A2 (pt) Método para fabricar composto, composição para o tratamento ou a prevenção da influenza, e, composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2377 DE 26-07-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.